原发性醛固酮增多症(PA)是一种常见的,但未被诊断为继发性高血压的原因。它的特点是醛固酮过量产生,导致高血压和/或低钾血症。尽管影响了5.9%至34%的高血压患者,由于缺乏临床意识和系统筛查,PA经常被遗漏。这可能导致严重的心血管并发症。为了解决这个问题,医学会制定了临床实践指南,以改善高血压和PA的管理。韩国内分泌学会,在大量研究的基础上,已经为PA制定了新的指导方针。已经成立了一个工作队来准备PA指南,包括流行病学,病理生理学,临床表现,诊断,治疗,和后续护理。韩国PA临床指南旨在提供基于证据的PA诊断方案,治疗,和病人监测。这些指南预计将减轻这种潜在可治愈的疾病的负担。
Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice
guidelines to improve the management of hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new
guidelines for PA. A task force has been established to prepare PA
guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical
guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These
guidelines are anticipated to ease the burden of this potentially curable condition.